ASPIC

Centro Cultural de Belém, Lisboa, Portugal

14-16 May, 2015

See more informations here: http://www.congresso-lusobrasileiro-oncologia.com/

Investigadoras do grupo de Genética do Cancro do Ipatimup (Joana Paredes e Ana Sofia Ribeiro) focam o seu estudo na Caderina-P, uma molécula de adesão celular que promove o crescimento tumoral e a invasão de células neoplásicas, sendo um marcador de mau prognóstico no cancro da mama.

Authors and Affiliations:

Ana Sofia Ribeiro and Joana Paredes ^1,2*
¹ Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
² Department of Pathology and Oncology, Faculty of Medicine of the University of Porto, Porto, Portugal

Abstract:

Authors and Affiliations: 

Olga Martinho^1,2,3, Luis E. Zucca³,Rui M. Reis^1,2,3*

¹Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho, Braga, Portugal;

²ICVS/3B’s - PT Government Associate Laboratory, Braga/Guimarães, Portugal;

³Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.

Abstract:

A descoberta de alterações na família de receptores tirosina quinase (RTK- receptor tyrosine quinases) e nas suas vias de sinalização intracelular têm possibilitado o desenvolvimento de fármacos específicos para estas moléculas, que conduziram a tratamentos oncológicos inovadores, personalizados e mais eficazes. No entanto, a resistência a estas terapias surge com o tempo, levando à recidiva e evolução tumoral. Esta abordagem de medicina personalizada tem sido aplicada no tratamento de glioblastoma, o mais frequente e maligno tumor cerebral.

TRANSCAN-2 is launching its first Joint Transnational Call for research proposals (JTC 2014) to which the European Commission (EC) will contribute. TRANSCAN-2 has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research.

The topic of the call will be «Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy» and projects must cover at least one of the areas specified below, which are equal in relevance for this call:

TRANSCAN-2 is launching its first Joint Transnational Call for research proposals (JTC 2014) to which the European Commission (EC) will contribute. TRANSCAN-2 has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research.

The topic of the call will be «Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy» and projects must cover at least one of the areas specified below, which are equal in relevance for this call:

Paris Marriott Rive Gauche Hotel & Conference Center, Paris, France

4 – 6 September, 2015

See more informations here: http://www.ilca2015.org/sitecore/content/be-bruga/ilca2015/index.aspx

Paris Marriott Rive Gauche Hotel & Conference Center, Paris, France

4 – 6 September, 2015

See more informations here: http://www.ilca2015.org/sitecore/content/be-bruga/ilca2015/index.aspx

Anargyrios and Korgialenios School, Spetses, Greece

16 - 24 August,  2015

See more informations here: http://mcr.umcutrecht.nl/upcoming-events/spetses-2015/